3 research outputs found
The application of a plant-wide control strategy for an integrated continuous pharmaceutical pilot plant.
Continuous manufacturing offers potential opportunities for the improved manufacturing of pharmaceutical products. A key challenge is the development of an appropriate control strategy. The experimental application of an automated control strategy is presented for an end-to-end continuous pharmaceutical pilot plant. The process starts from an advanced intermediate compound and finishes with the tablet formation steps. The focus of the experimental results is on the design and performance of the control loops needed to produce a slurry of an active pharmaceutical ingredient and a solvent with specified material properties. The results demonstrate that automated control can successfully keep critical material attributes close to the desired set points for a sustained period of operation. This work aims to contribute to the development of future continuous pharmaceutical processes by providing a realistic case study of automated control of an integrated, continuous, pharmaceutical pilot plant
Development of a multi-step synthesis and workup sequence for an integrated, continuous manufacturing process of a pharmaceutical
The development and operation of the synthesis and workup steps of a fully integrated, continuous manufacturing plant for synthesizing aliskiren, a small molecule pharmaceutical, are presented. The plant started with advanced intermediates, two synthetic steps away from the final active pharmaceutical ingredient, and ended with finished tablets. The entire process was run on several occasions, with the data presented herein corresponding to a 240 h run at a nominal throughput of 41 g h-1 of aliskiren. The first reaction was performed solvent-free in a molten condition at a high temperature, achieving high yields (90%) and avoiding solid handling and a long residence time (due to higher concentrations compared to dilute conditions when run at lower temperatures in a solvent). The resulting stream was worked-up inline using liquid-liquid extraction with membrane-based separators that were scaled-up from microfluidic designs. The second reaction involved a Boc deprotection, using aqueous HCl that was rapidly quenched with aqueous NaOH using an inline pH measurement to control NaOH addition. The reaction maintained high yields (90-95%) under closed-loop control despite process disturbances. © 2014 American Chemical Society
Development of a Multi-Step Synthesis and Workup Sequence for an Integrated, Continuous Manufacturing Process of a Pharmaceutical
The development and operation of the synthesis and workup steps
of a fully integrated, continuous manufacturing plant for synthesizing
aliskiren, a small molecule pharmaceutical, are presented. The plant
started with advanced intermediates, two synthetic steps away from
the final active pharmaceutical ingredient, and ended with finished
tablets. The entire process was run on several occasions, with the
data presented herein corresponding to a 240 h run at a nominal throughput
of 41 g h<sup>–1</sup> of aliskiren. The first reaction was
performed solvent-free in a molten condition at a high temperature,
achieving high yields (90%) and avoiding solid handling and a long
residence time (due to higher concentrations compared to dilute conditions
when run at lower temperatures in a solvent). The resulting stream
was worked-up inline using liquid–liquid extraction with membrane-based
separators that were scaled-up from microfluidic designs. The second
reaction involved a Boc deprotection, using aqueous HCl that was rapidly
quenched with aqueous NaOH using an inline pH measurement to control
NaOH addition. The reaction maintained high yields (90–95%)
under closed-loop control despite process disturbances